British Journal of Cancer publishes first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK.
British Journal of Cancer publishes NET Patient Foundation’s research into impact of neuroendocrine morphology on cancer outcome and stage at diagnosis NET Patient Foundation in collaboration with Public Health England have undertaken the first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK to identify areas of unmet need with an aim to inform service improvement.
Recent News
Neuroendocrine Cancer – The Expert Patient: Podcast on neuroendocrine cancer to raise awareness among GPs
As part of our ‘spotlight on neuroendocrine cancer’ campaign which aims to raise awareness of neuroendocrine cancer among healthcare professionals, we have been working with the Primary Care Society of Gastroenterology to raise awareness of neuroendocrine cancer for...
Launching the Neuroendocrine Life Alliance
Neuroendocrine Cancer UK and the Association for Multiple Endocrine Neoplasia Disorders (AMEND) are proud to announce the launch of the Neuroendocrine Life Alliance. This exciting new collaboration between Neuroendocrine Cancer UK and the Association for Multiple...
The First-Ever World Hormone Day – Today, 24th April 2025
24 April 2025 – The first World Hormone Day takes place today to raise awareness of the vital role of hormones in rare and chronic disease. Under the banner of #BecauseHormonesMatter, the campaign brings together the global endocrine community to share the small steps...